UMIN-CTR Clinical Trial

Recruitment status Completed
Unique ID issued by UMIN UMIN000039545
Receipt No. R000045002
Scientific Title A retrospective study on the effect of resection, laser treatment, and risk factors for malignant transformation and postoperative recurrence in vocal fold leukoplakia
Date of disclosure of the study information 2020/02/20
Last modified on 2020/02/20 (Ver. 1)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Public title A retrospective study on the effect of resection, laser treatment, and risk factors for malignant transformation and postoperative recurrence in vocal fold leukoplakia
Acronym A retrospective study on the effect of resection, laser treatment, and risk factors for malignant transformation and postoperative recurrence in vocal fold leukoplakia
Scientific Title A retrospective study on the effect of resection, laser treatment, and risk factors for malignant transformation and postoperative recurrence in vocal fold leukoplakia
Scientific Title:Acronym A retrospective study on the effect of resection, laser treatment, and risk factors for malignant transformation and postoperative recurrence in vocal fold leukoplakia
Region
Japan

Condition
Condition Vocal fold leukoplakia
Classification by specialty
Oto-rhino-laryngology
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 We compare the clinical characteristics of patients with vocal fold leukoplakia who have visited our hospital with those who have not recurred and clarify the differences. In addition, the objective was to reduce the burden on patients to formulate a treatment policy, take countermeasures, and reduce recurrent cases.
Basic objectives2 Others
Basic objectives -Others Vocal fold leukoplakia is a benign disease caused by hoarseness, caused by the thickening of the squamous epithelium. The causes include various stages from temporary hyperplasia associated with inflammation such as the common cold to dysplasia involving infiltration of atypical cells into the epithelium and cancer. It is known that even if hyperplasia is found in pathological diagnosis by tissue biopsy, malignant transformation occurs only by follow-up observation. Extensive resection for complete removal of lesions impairs speech function. In addition, the canceration of recurrent lesions is still being reported. If this study reduces the rate of recurrence of vocal fold leukoplakia, it can prevent cancer associated with the recurrence and reduce the psychological, physical, and economic burden on patients associated with treatment for the recurrence.
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes The postoperative recurrence rate of vocal fold leukoplakia
Key secondary outcomes Gender, age, drinking history, smoking history, pathological diagnosis, pharyngolaryngeal reflux, unilateral or bilateral vocal cord lesions, lesion length relative to the total length of the vocal cords, postoperative follow-up period, presence or absence of inferior surface lesions, associative lesions Presence/absence of laryngeal expansion

Base
Study type Others,meta-analysis etc

Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
20 years-old <=
Age-upper limit
90 years-old >
Gender Male and Female
Key inclusion criteria Those that meet all of the following criteria

Vocal cord leukoplakia

Age: 20 years old or older, less than 90 years old

Gender: both gender

They were the first to undergo surgery for the above disease at Nihon University Hospital.

Surgery involves both tissue sampling and resection of the lesion and Ho; YAG laser treatment
Key exclusion criteria Diagnosis of pathological carcinoma in situ and invasive carcinoma and those who have previous treatment
Target sample size 39

Research contact person
Name of lead principal investigator
1st name Hisashi
Middle name
Last name Hasegawa
Organization Nihon University Hospital
Division name Otorhinolaryngology and Head and Neck Surgery
Zip code 101-8309
Address 1-6, Kandasurugadai
TEL 0332931711
Email hasegawa.hisashi@nihon-u.ac.jp

Public contact
Name of contact person
1st name Hisashi
Middle name Hasegawa
Last name Hasegawa
Organization Nihon University Hospital
Division name Otorhinolaryngology and Head and Neck Surgery
Zip code 101-8309
Address 1-6, Kandasurugadai
TEL 0332931711
Homepage URL
Email hasegawa.hisashi@nihon-u.ac.jp

Sponsor
Institute Nihon University Hospital
Institute
Department

Funding Source
Organization Nihon University Hospital
Organization
Division
Category of Funding Organization Self funding
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

IRB Contact (For public release)
Organization Otorhinolaryngology and Head and Neck Surgery
Address 1-6, Kandasurugadai
Tel 03-3293-1711
Email hasegawa.hisashi@nihon-u.ac.jp

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2020 Year 02 Month 20 Day

Related information
URL releasing protocol
Publication of results Unpublished

Result
URL related to results and publications
Number of participants that the trial has enrolled 39
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description

Progress
Recruitment status Completed
Date of protocol fixation
2019 Year 08 Month 01 Day
Date of IRB
2019 Year 09 Month 16 Day
Anticipated trial start date
2019 Year 08 Month 01 Day
Last follow-up date
2019 Year 12 Month 31 Day
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Other
Other related information A retrospective review

Management information
Registered date
2020 Year 02 Month 20 Day
Last modified on
2020 Year 02 Month 20 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000045002